Table: begin end state 1 20 cytoplasmic 21 43 transmembrane 44 48 non-cytoplasmic 49 76 transmembrane 77 85 cytoplasmic 86 109 transmembrane 110 114 non-cytoplasmic 115 116 transmembrane 117 118 non-cytoplasmic 119 140 transmembrane 141 151 cytoplasmic 152 177 transmembrane 178 184 non-cytoplasmic 185 205 transmembrane 206 234 cytoplasmic 235 254 transmembrane 255 273 non-cytoplasmic 274 293 transmembrane 294 302 cytoplasmic 303 324 transmembrane 325 335 non-cytoplasmic 336 356 transmembrane 357 367 cytoplasmic 368 389 transmembrane 390 398 non-cytoplasmic 399 417 transmembrane 418 433 cytoplasmic
Input: >RR42_RS07875 MSSSPSQQHGFRTVFRVVSGNFLEMYDFMVYGFYAAAIAKTFFPSGNEFASLMLSLATFG AGFLMRPLGAIILGAYIDHHGRRKGLIMTLVLMALGTLLIACVPGYASIGVAAPLLVLAG RLLQGFSAGVELGGVSVYLAEIAKPGKKGFYVAWQSASQQVAVIFAGLLGVVLHSMLSPE EMGEWGWRIPFLIGCLIVPFLFLIRRSLEETEEFKTRKHRPSISEIYRSMMENWRIIVAG CMMVVMTTVSFYMITAYTPTFGKTVLKLDDVDNLIVTMCVGLSNFIWLPLMGALSDRVGR KPLLVIFTILTLLTAYPAVSWLVAEPSFGRLLMVELWLSFLYGSYNGAMVVTLTEVMPPA VRTAGFSLAYSLATALFGGFTPAISTYLIHSTGNKAAPGLWLMFAAACGLIATLVIFRGG RQHAYVEPAAKTA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server